Active and passive immunization with rHyr1p-N protects mice against hematogenously disseminated candidiasis
about
Studies of Immune Responses in Candida vaginitisEmerging drugs and vaccines for candidemiaVaccine immunity against fungal infectionsPurpurin suppresses Candida albicans biofilm formation and hyphal development.New approaches in the development of a vaccine for mucosal candidiasis: progress and challengesActive immunizations with peptide-DC vaccines and passive transfer with antibodies protect neutropenic mice against disseminated candidiasisAdhesins in human fungal pathogens: glue with plenty of stick.Universal fungal vaccines: could there be light at the end of the tunnel?Immune modulators as adjuncts for the prevention and treatment of invasive fungal infections.Candida antigens and immune responses: implications for a vaccine.Beyond Candida albicans: Mechanisms of immunity to non-albicans Candida speciesImmunotherapy of Fungal Infections.Testing Antifungal Vaccines in an Animal Model of Invasive Candidiasis and in Human Mucosal Candidiasis.The Elusive Anti-Candida Vaccine: Lessons From the Past and Opportunities for the Future.The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection.Human Anti-Als3p Antibodies Are Surrogate Markers of NDV-3A Vaccine Efficacy Against Recurrent Vulvovaginal Candidiasis.
P2860
Q26782272-DF369E80-9372-4731-ACFD-16E17126A913Q26828993-5725EBB2-1BD6-4A51-9355-A11033890981Q27009819-3444D497-A250-495C-86A7-65DD810219B7Q34506049-8E7372C0-C3AD-4714-92CB-FCC692D89416Q36158337-7B68797B-48AB-4301-9C87-614176B0408CQ36421907-46A08455-6DB2-44B6-9993-CACC542DD116Q36757905-D04AD626-454A-4480-AD29-3F8271E2EBEEQ38038044-17AABDCE-2051-4783-9F50-CF97A49088D1Q38067451-13FC4344-D669-4E54-8CE9-27E702161C7FQ38222636-9F42B7C5-A0C3-4DF6-A8DB-62D1B371E644Q38567197-7142C7D7-D95C-4E5E-9AD8-84AA77672BB5Q38635409-230CC26B-C055-45F7-B961-02F81133BA7CQ40183727-8807F238-3074-4309-B3F5-6FA4EFBD3D99Q53683158-FD43674A-988C-42AC-A389-546C21C2124CQ54215616-C02900F6-95D3-4600-A813-AFB4A2365A7CQ55396489-1A0747B1-7CD9-4F19-B170-7B3E6224CA59
P2860
Active and passive immunization with rHyr1p-N protects mice against hematogenously disseminated candidiasis
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Active and passive immunizatio ...... ously disseminated candidiasis
@ast
Active and passive immunizatio ...... ously disseminated candidiasis
@en
Active and passive immunizatio ...... ously disseminated candidiasis
@nl
type
label
Active and passive immunizatio ...... ously disseminated candidiasis
@ast
Active and passive immunizatio ...... ously disseminated candidiasis
@en
Active and passive immunizatio ...... ously disseminated candidiasis
@nl
prefLabel
Active and passive immunizatio ...... ously disseminated candidiasis
@ast
Active and passive immunizatio ...... ously disseminated candidiasis
@en
Active and passive immunizatio ...... ously disseminated candidiasis
@nl
P2093
P2860
P1433
P1476
Active and passive immunizatio ...... ously disseminated candidiasis
@en
P2093
Ashraf S Ibrahim
Guanpingsheng Luo
John E Edwards
Samuel W French
P2860
P304
P356
10.1371/JOURNAL.PONE.0025909
P407
P577
2011-01-01T00:00:00Z